Author:
Kim Anne B.,Cheng Brian T.,Hassan Shahzeb
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Reference25 articles.
1. Azziz R (2003) The evaluation and management of hirsutism. Obstet Gynecol 101(5):995–1007
2. Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, Pugeat M, Qiao J, Wijeyaratne CN, Witchel SF, Norman RJ (2012) Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod 18(2):146–170
3. Comim FV, Wippel CS, Copês RM, Langer FW, Carvalho JM, Moresco RN, Premaor MO (2017) Higher prevalence of clinical cardiovascular comorbidities in postmenopausal women with self-reported premenopausal hirsutism and/or oligo-amenorrhea. Dermato-endocrinology 9(1):e1356517
4. Cooney LG, Lee I, Sammel MD, Dokras A (2017) High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 32(5):1075–1091
5. Ekbäck MP, Lindberg M, Benzein E, Årestedt K (2013) Health-related quality of life, depression and anxiety correlate with the degree of hirsutism. Dermatology (Basel, Switzerland) 227(3):278–284